These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38055839)

  • 1. Using the PharmCAT tool for Pharmacogenetic clinical decision support.
    Tippenhauer K; Philips M; Largiadèr C; Sariyar M
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38055839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PharmCAT: A Pharmacogenomics Clinical Annotation Tool.
    Klein TE; Ritchie MD
    Clin Pharmacol Ther; 2018 Jul; 104(1):19-22. PubMed ID: 29194583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
    Hoffman JM; Dunnenberger HM; Kevin Hicks J; Caudle KE; Whirl Carrillo M; Freimuth RR; Williams MS; Klein TE; Peterson JF
    J Am Med Inform Assoc; 2016 Jul; 23(4):796-801. PubMed ID: 27026620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iterative Development and Evaluation of a Pharmacogenomic-Guided Clinical Decision Support System for Warfarin Dosing.
    Melton BL; Zillich AJ; Saleem J; Russ AL; Tisdale JE; Overholser BR
    Appl Clin Inform; 2016 Nov; 7(4):1088-1106. PubMed ID: 27878205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Pharmacogenetic Decision Support into a Clinical Information System.
    Tippenhauer K; Philips M; Largiadèr CR; Sariyar M; Bürkle T
    Stud Health Technol Inform; 2020 Jun; 270():618-622. PubMed ID: 32570457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
    Caudle KE; Dunnenberger HM; Freimuth RR; Peterson JF; Burlison JD; Whirl-Carrillo M; Scott SA; Rehm HL; Williams MS; Klein TE; Relling MV; Hoffman JM
    Genet Med; 2017 Feb; 19(2):215-223. PubMed ID: 27441996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support.
    Liu M; Rossow KM; Maxwell-Horn AC; Saucier LA; Van Driest SL
    Pharmacotherapy; 2023 Jul; 43(7):691-704. PubMed ID: 36524442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy.
    Roncato R; Dal Cin L; Mezzalira S; Comello F; De Mattia E; Bignucolo A; Giollo L; D'Errico S; Gulotta A; Emili L; Carbone V; Guardascione M; Foltran L; Toffoli G; Cecchin E
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30987397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
    Blazy C; Ellingrod V; Ward K
    Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating Shareable Clinical Decision Support Rules for a Pharmacogenomics Clinical Guideline Using Structured Knowledge Representation.
    Linan MK; Sottara D; Freimuth RR
    AMIA Annu Symp Proc; 2015; 2015():1985-94. PubMed ID: 26958298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic considerations in the elderly patient.
    Bright DR; Calinski DM; Kisor DF
    Consult Pharm; 2015 Apr; 30(4):228-39. PubMed ID: 25893701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of precision statin prescribing for reduction of statin-associated muscle symptoms.
    Petry NJ; Baye JF; Frear S; Jacobsen K; Massmann A; Schultz A; Heukelom JV; Christensen K
    Pharmacogenomics; 2022 Jul; 23(10):585-596. PubMed ID: 35775396
    [No Abstract]   [Full Text] [Related]  

  • 19. Technical Challenges and Opportunities when Implementing Pharmacogenomics Decision Support Integrated in the Electronic Health Record.
    Caraballo PJ; Sutton JA; Moyer AM; Blair D; Hines LC; Rao PS; Adams MF; Murthy S; Garza T; Karow ME; Singh H; Giri J; Gabrielson DB; Sauver JS; Bielinski SJ; Parkulo MA
    Stud Health Technol Inform; 2017; 245():1255. PubMed ID: 29295340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
    Chang WC; Tanoshima R; Ross CJD; Carleton BC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.